hapabapa
- Leerink has upgraded AbbVie (NYSE:ABBV) to outperform from market perform, commenting that the recent sell-off in the shares has created a buying opportunity.
- “We believe investors can take advantage of the emraclidine setback and election-related downdraft to purchase shares in